首页> 外国专利> LACTIC ACID BACTERIA INHIBITING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND PROBIOTICS COMPOSITION COMPRISING SAME

LACTIC ACID BACTERIA INHIBITING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND PROBIOTICS COMPOSITION COMPRISING SAME

机译:抑制耐甲氧西林金黄色葡萄球菌的乳酸菌及其组成的组成

摘要

The present invention relates to Lactobacillus salivarius lactic acid bacteria having an inhibitory ability for methicillin-resistant Staphylococcus aureus (MRSA), and a probiotics composition comprising the same. The Lactobacillus salivarius PG1230 lactic acid bacteria according to the present invention has an inhibitory effect of methicillin-resistant Staphylococcus aureus, acid resistance, bile resistance, and intestine attachment ability, thereby being practically used as probiotics capable of replacing antibiotics. Also, bacteriocin, which is one of antibiotic materials produced by the lactic acid bacteria, is formed of protein or peptide materials, and is decomposed by protease in digestive organs of human body, thereby having no toxicity, and remaining properties.;COPYRIGHT KIPO 2014
机译:本发明涉及对耐甲氧西林的金黄色葡萄球菌(MRSA)具有抑制能力的唾液乳杆菌乳酸菌,以及包含该乳酸菌的益生菌组合物。根据本发明的唾液乳杆菌PG1230乳酸菌具有耐甲氧西林的金黄色葡萄球菌的抑制作用,耐酸性,耐胆汁性和肠附着能力,从而实际上用作能够代替抗生素的益生菌。另外,细菌素是乳酸菌产生的一种抗生素,它是由蛋白质或肽类物质形成,并在人体的消化器官中被蛋白酶分解,因此没有毒性和残留特性。; COPYRIGHT KIPO 2014

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号